Oncology Research Assays

Fully automated detection of 46 EGFR mutations, directly from 1 FFPE tissue section.

Fully automated detection of ALK, ROS1, RET, NTRK1/2/3 rearrangements & MET exon 14 skipping, directly from 1 FFPE tissue section.

Fully automated detection of 7 BRAF mutations, directly from 1 FFPE tissue section.

Fully automated detection of 17 POLE mutations and 1 POLD1 mutation, directly from 1 FFPE tissue section.

Fully automated detection of 21 KRAS mutations, directly from 1 FFPE tissue section.

Fully automated detection of 18 NRAS mutations, 5 BRAF mutations and 2 EGFR mutations, directly from 1 FFPE tissue section.

* UNDER DEVELOPMENT
Fully automated, first-in-class cartridge-based assay for indeterminate thyroid nodules.

Fully automated detection of 5 IDH mutations and 10 IDH2 mutations, directly from FFPE tissue sections, whole blood, BMA or extracted DNA.

*TEMPORARILY UNAVAILABLE

Fully automated detection of 13 PIK3CA mutations and 1 AKT1 mutation, directly from 1 FFPE tissue section.

Fully automated detection of 49 EGFR mutations, directly from 2 ml of plasma.

Fully automated detection of 21 KRAS mutations, directly from 1 ml of plasma.

Fully automated detection of 18 NRAS, 5 BRAF and 2 EGFR mutations, directly from 1 ml of plasma.

Qualitative detection of 11 ESR1 mutations via quantitative PCR (qPCR), using DNA extracted from FFPE tissue section or plasma.